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Padded socks to protect the at-risk diabetic foot have been available for a number of years. However, the evidence
base to support their use is not well known. We aimed to undertake a systematic review of padded socks for people
with diabetes. Additionally, a narrative analysis of knitted stitch structures, yarn and fibres used together with the
proposed benefits fibre properties may add to the sock. Assessment of the methodological quality was undertaken
using a quality tool to assess non-randomised trials. From the 81 articles identified only seven met the inclusion
criteria. The evidence to support to use of padded socks is limited. There is a suggestion these simple-to-use
interventions could be of value, particularly in terms of plantar pressure reduction. However, the range of methods
used and limited methodological quality limits direct comparison between studies. The socks were generally of a
sophisticated design with complex use of knit patterns and yarn content. This systematic review provides limited
support for the use of padded socks in the diabetic population to protect vulnerable feet. More high quality
studies are needed; including qualitative components of sock wear and sock design, prospective randomized
controlled trials and analysis of the cost-effectiveness of protective socks as a non-surgical intervention.
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Diabetes mellitus, particularly the mature onset or type-
two variation (T2DM) is a major health concern world-
wide [1-3]. T2DM is a cause of significant co-morbidity
and is predicted to further increase over the next
20 years contributing to a greater diabetes-related bur-
den [1,4-6]. Some 15%-25% of people with diabetes will
suffer a foot ulcer [7,8] and limb amputation is preceded
by foot ulceration in 85% of cases [9]. More worryingly
it is suggested that some 80% of amputations are pre-
ventable [10]. The aetiology of foot ulcers is complex
and has been extensively reviewed [11-14]. Complica-
tions (including vascular disease, peripheral neuropathy,
increased mechanical stress and Charcot neuroarthropa-
thy) greatly increase the incidence of lower limb ampu-
tations [14-17]. However, the nature of diabetes means
even those at low risk can develop foot complications
[18], particularly in the presence of poor glycaemic* Correspondence: krome@aut.ac.nz
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unless otherwise stated.control and/or a lack of regular foot assessment. Foot
complications negatively impact individuals’ quality of
life and their ability to be productive members of society
and these complex pathologies are a considerable health
system burden [19-21].
A range of non-surgical approaches can be used to
prevent the foot complications seen in diabetes includ-
ing education, self-care/self-monitoring of feet, appropri-
ate skin and nail care, wearing supportive footwear and
protective socks, as well as formal podiatric assessment
and treatment [22-24]. From a commercial perspective a
vast range of protective socks are commercially available
(Additional file 1). Recent studies in diabetic foot ulcer
prevention have reported on foot orthoses and footwear
to reduce foot pressure [25,26]. A systematic review [27]
considered ‘socks for people with diabetes’ but did not
present any formal scoring, yet determined results
for this type of hosiery were inconclusive. A recent
Cochrane review appraised off-loading strategies, but didhis is an Open Access article distributed under the terms of the Creative
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to undertake a systematic review of protective socks for
people with diabetes and included a narrative analysis of
these socks, which included an analysis of the knitted
stitch structure and yarn/fibre type.
Review
Methods
This systematic review was undertaken according to the
guidelines provided by the Cochrane Collaboration [29]
and the PRISMA group [30].
Search and selection process
To obtain all articles relating to the use of socks for
people with diabetes an extensive literature search was
designed jointly by the lead author (SO) and an experi-
enced librarian (AS) performed across several databases
EBSCO (Biomedical reference collection, Cinhal, Health
business elite, Health source, Medline, Sport discuss)
SCOPUS, AMED, Cochrane and PEDro. Databases were
searched from 1985 – 2014, as socks for people with dia-
betes were not available prior to 1985. Further searches
of manufacturer’s websites were also conducted.
Publications were identified through a search that used
the following MeSh terms: (diabet* AND sock) OR (dia-
bet* AND socks) OR (diabet* AND hosiery) OR (diabet*
AND padded). Articles were limited to “humans” and
“English”. Inclusion criteria comprised articles reporting
any type of clinical trial design, including people with dia-
betes reporting the use of socks for people with diabetes.
Articles were initially excluded if they did not report
diabetes; did not focus on socks for people with diabetes
as a mechanism for foot protection reduction, (for
example articles reporting the use of hosiery to control
oedema). Articles relating to non-diabetic groups, for ex-
ample, healthy populations or sports were also excluded.
Owing to a paucity of high quality research, studies were
included if they were of level four or above [31] and in
English language. Reviews, editorials, letters and single
case histories were excluded. The selection process was
performed on the titles of articles, the abstract then on full
text (Figure 1).
General data extraction
Publications were evaluated based on the full text
article and reviewers were not blinded to the journal
title or authors. Information was extracted based on
year of publication, study design and number of
participants. Demographic data such as gender, age,
duration of diabetes, disease features and length of
follow-up was also recorded. Publications were reviewed
with the use of a tool developed by Downs & Black
[32]. While the Cochrane Collaboration [29] does not
recommend a specific tool for non-randomised clinicaltrials, this instrument has been widely used for non-
pharmacological trials and provides a score between
0-32 across 27 questions: a higher score representing
robust, high quality methodology. The tool is easy to
complete with high internal consistency, test-retest and
inter-rater reliability reported to be good by the authors
[32]. The checklist covers study quality (10 items), ex-
ternal validity (3 items), bias (7 items), confounding
and selection bias (6 items) and the power of the study
(1 item) [33].
Statistical Analysis
Analysis was mainly descriptive based on an analysis of
the narrative provided by studies, i.e. the extent to which
plantar pressures were reduced; together with the
Downs and Black score for each article. In this review
four questions (7, 15, 16 and 25) were omitted from the
Downs & Black tool as these were not applicable to any
of the trials being reviewed. Each score is therefore
expressed as a percentage to permit ease of comparison.
Description of publications
A total of 81 articles were retrieved, but we identified
only seven prospective studies [34-40] that met the in-
clusion criteria. A further five papers [41-45] consid-
ered the role of protective socks in other populations
(e.g. athletes’ or rheumatoid arthritis). While these
findings may be transferrable to the diabetic popula-
tion, they were excluded from the review. From the
additional 70 articles that were excluded, many were
duplicates (n = 23). Others were industry reports
highlighting new product developments (n = 12), but
not providing any empirical evidence to support the
product (Figure 1). A further 18 papers consisted of
education and/or continuing professional development
articles for health professionals highlighting the need
to protect the ‘at risk’ diabetic foot. Of the seven
studies included, three were case series, three cross
sectional designs and one single blind RCT. The main
characteristics of the studies reviewed are presented in
Table 1. The mean quality score was 39% (SD 20, range
17-78%) - details in Table 2.
Plantar foot pressure
Five studies [34-38,40] used peak plantar pressure as the
primary outcome measure. A variety of protective socks
were included. Additionally, most studies also included a
control element with subjects using their own socks
or standard shop-bought socks together with barefoot
pressure measurements as a true control condition.
Three studies [35-37] reported padded socks provided a
significant reduction in peak plantar pressure. They
suggest that in conjunction with wearing proper foot-
wear/orthoses, padded socks could help prevent foot
Figure 1 PRISMA diagram to show selection of publications.
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increase in peak plantar pressure with padded socks.
One study reported a follow-up period [36] and a sig-
nificant reduction in peak plantar pressure was main-
tained at 6 months, although this reduction was not as
great as was seen at baseline.
Plantar contact area
One study [40] reported plantar contact area as an out-
come and reported a significantly greater contact area
with socks for people with diabetes compared withordinary shop-bought socks. These authors demon-
strated an increase in maximum foot contact area of
11 cm2 when subjects wore the protective socks, ac-
companied by a 9% reduction in total foot pressure.
Similar results were observed at the forefoot, a 14%
increase in contact area and 10% reduction in peak
forefoot pressure.
Patient satisfaction
One study used a survey design approach to quantify
how satisfied subjects were with socks designed to
Table 1 Overview of studies reviewed
Study Demographic data Inclusion criteria (in addition to diabetes) Findings
Blackwell et al. [34] N° of subjects 21 Diabetes with foot complaints, no active
ulceration
Plantar pressure assessed with Parotec system
Gender 10 M : 11 F
Mean age (range) 57.4 (20-83) No significant difference between JBOST diabetic sock,
normal sock or barefoot
Diabetes duration Not stated
Veves et al. [35] N° of subjects 27 High plantar pressures (>10 kg/cm2) Plantar pressure assessed with optical pedobarograph
Gender 15 M: 2 F Neuropathy (diminished nerve conduction
& vibration perception)
Experimental socks [Thorlo] provided significant pressure
reduction compared with pts own socks or barefoot (both
p < 0.001)Mean age (range) 54 (26-74)
Diabetes duration not stated Able walk unaided, no PVD, no ulcer history
Veves et al. [36] Gender not stated Neuropathy (diminished vibration
perception & absent ankle reflex)
Plantar pressure assessed with optical pedobarograph
Experimental group (n = 10)
mean age (range) 51.3 (27-65)
Duration of diabetes not stated Significant reduction in pressure of experimental socks
[Thorlo] compared with padded sports socks & barefoot
(all p < 0.001). Pressure reduction maintained by
experimental socks at 3 & 6 months.
Control group n = 16
Mean age (range) 55.8 (33-70)
Garrow et al. [37] N° of subjects 19 Neuropathy (neuropathy disability score >5
or diminished vibration perception ≥25).
Plantar pressure assessed with F-scan system
Gender 15 M:4 F
Mean age (range) 65.5 (39-80) Ulcer-free at recruitment Preventative Foot Care Diabetic socks provided significant
increase in foot contact area (p < 0.01), a reduction total
pressure (p < 0.01).Diabetes duration median 20 yrs High plantar pressure (≥6 kg/cm
2).
Murray et al. [38] N° of subjects 86 Neuropathy (diminished pressure or
vibration perception)
Questionnaire based satisfaction survey over 6 month
period using Thorlo socks
Gender 69 M :17 F
Mean age (range) 63 (34-85) No active ulceration Socks reported good/very good by 86%, average by
12% & poor by 3%.
Mean diabetes (range) 16 (1–45 yrs 84% reported continue sock use at 3 & 6 months
Banchellini et al. [39] N° of subjects 30 Peripheral neuropathy (ADA criteria) Skin parameters tested:
Gender not stated Hydration (hydration score) Hardness (Durometer)
Group A (Difoprev) socks Anhidrosis (Clinical features
& Neuropad test)
Moisture loss (Scalar moisture checker)
Mean age 59.6 (SD13.8) Water loss (TEWL vapometer)
Duration diabetes 16.1 (SD9) No active ulceration, ABPI >0.9, Serum
creatinine >2 mg/dL
All skin parmeters improved over 6 week trial (Difoprev)
socks & normal socks
Group B (no active sock ingredient)
Mean age 61.4 (SD15.5) Skin hydration p < 0.01 Skin hardness p <0.05
Duration diabetes 15.7 (SD6.9) No systemic skin disease, no B-blocker
therapy
Controls (normal socks) Skin moisture loss p < 0.01 Skin water loss p < 0.01
Mean age 60.5 (SD11.4)
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Table 1 Overview of studies reviewed (Continued)
Yick et al. [40] No of subjects 4 No inclusion criteria stated Plantar pressure (Pedar system)
Gender not stated Skin temperature & humidity (system not stated)
Age not stated Socks tested not stated
Diabetes duration not stated Considerable pressure reduction stated but not per sock type
Thermal properties are stated but not compared between
socks or post sock wear
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Table 2 Description of scoring ba ed on Downs & Black criteria
Study Is the
aim of
the
study
clear?
Are the
main
outcomes
clearly
described?
Are
chara eristics
of pa nts
includ d
clearl
descr ed?
Are the
interventions
clearly
described?
Are
co-founders
clearly
described?
Are the
main
findings
clearly
described?
Have
adverse
events
been
reported?
Are subjects
lost to
follow up
characteristics
reported?
Are actual
probability
values
reported?
Were subjects
invited
representative
of population
Subjects who
participated
representative
of population?
Were staff,
places &
facilities
representative?
Was there
an attempt
to blind
study
subjects?
Veves et al.
[37]
X X X X O O X U O U X X O
Veves et al.
[38]
X X X X O X X U O U U X O
Murray
et al. [40]
X O X X X O X U O U U U O
Blackwell
et al. [36]
X O O X O O O O O U U U O
Garrow
et al. [39]
X X X X X X U O O U U X O
Banchellini
et al. [41]
X X X X X X X U O X X X X
Yick et al.
[42]
X X O X O O O U O U U U O
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Table 2 Description of scoring based on Downs & Black criteria (Continued)
Study Were analyses
adjusted for
different
lengths of
follow-up
between
interventions?
Were appropriate
Statistical
tests used?
Was
compliance
with
interventions
reliable?
Were main
outcome
measures
accurate and
reliable?
Were cases/
controls
recruited
from same
population?
Were cases/
controls
recruited
over same
time?
Were
subjects
randomized
to
intervention
groups?
Was randomized
intervention
concealed
form subjects
& clinicians?
Are analyses
adjusted for
lost to follow
up subjects
Study have
sufficient
power to
detect
clinically
important
effect?
Total
score (%)
based on
23 items
Veves et al.
[37]
U X X X U U U U U O 10 (43.5%)
Veves et al.
[38]
O X X X U U U U U O 10 (43.5%)
Murray
et al. [40]
U U X U U U U U U U 6 (26.1%)
Blackwell
et al. [36]
U X X X U U U U O O 5 (21.8%)
Garrow
et al. [39]
U U U X U U X O O U 9 (39.2%)
Banchellini
et al. [41]
X X X X X X X O U U 18 (78.3%)
Yick et al.
[42]
O U U X U U U U U O 4 (17.4%)
X = yes, O = no, U = unable to tell.
Questions omitted: 7 - no trials reported the random variability for their main outcomes, 15 - none of the studies were double-blind, 16 - there was no evidence of data dredging, 25 - cofounding variables were not
adjusted for throughout.
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were positive; with 85% reporting high satisfaction, and
84% of participants reported they wished to continue
wearing the socks after the trial.
Skin moisture and temperature
Banchellini et al. [39] reported in a 6-week randomised
trial into a new nanotechnology impregnated sock de-
sign intended to increase skin moisture content. The
sock (Difoprev system, LVM technologies Italy) con-
sisted of a synthetic polyammide fibre loaded with
microcapsules of an emollient agent. Additionally, Yick
et al. [40] noted an increase in skin temperature and
humidity with protective socks in a sample of two
subjects with diabetes.
From this review there is weak evidence that protect-
ive socks may reduce foot pressures and provide add-
itional protection for the at-risk foot in diabetes. There
are four domains (plantar pressure, plantar contact area,
satisfaction and skin moisture) that reflect relevant
clinical outcomes and are reported in research articles
over 25 years. However, in spite of sophisticated sock
design and material usage employed by manufacturers,
studies received low scores using the Downs and Black
instrument. The majority of studies compared very small
populations and were not adequately powered. This
together with limitations in the overall design (e.g. lack
of randomization, blinding of participants and/or
clinicians) also contributed to low scores. While it is
difficult to blind clinicians working in healthcare
settings, the guidance offered by Boultron et al. [46]
and Cook [47] are essential as a lack of non-blinded
assessors can cause a high risk of observer bias [48]. In
most studies some attempt was made to identify par-
ticipants with diabetes who would benefit more from
protective socks (i.e. those with higher plantar pres-
sures and loss of protective sensation), which might
also suggest greater improvements would be reported.
However, not all articles controlled for the complica-
tions commonly seen in diabetes (e.g. vascular disease,
current foot ulceration or previous amputation). While
this may represent the heterogeneous nature of foot
complaints seen in diabetes, equally there were no
clear attempts to include adequate numbers of subjects
with these complications to represent the heteroge-
neous nature of foot complaints seen in the diabetic
population. Moreover, the contention of many articles
was that reducing foot pressure would prevent foot
ulceration. However, the incidence of foot ulceration
was not a primary outcome measure and not always
stated as an adverse event.
Plantar pressures have long been recommended as a
key outcome measure to identify those at risk of foot
ulceration [17,49]. Notably, up to three-quarters of footulcers are over the metatarsal head region [50] – often
an area of high pressure. Ulbrect et al. [26] report that
peak barefoot plantar pressure is the key determinant
when manufacturing bespoke orthoses to off-load
pressure. A significant reduction in plantar pressure
was reported by three studies while using protective
socks [35-37]. However, considerable variations be-
tween peak plantar pressure values have also been
reported for those with and without foot ulcers
[26,51,52]. These differences may be due to a number
of factors, including the protocol and equipment used.
In the articles we reviewed, research protocols were
often not clearly described. That said, many were pub-
lished prior to the development of guidelines for plan-
tar pressure studies [53]. Additionally, footwear is
often a key therapeutic intervention; [27,54] so con-
trolling for, or standardising footwear should also be a
consideration when designing research protocols when
testing protective socks. Foot structure, biomechanics
and tissue glycation may have a marked effect on plantar
pressure variables [55-57] and these variables should also
be considered either as part of the exclusion criteria or as
potential confounders when assessing the impact of pro-
tective socks on plantar pressures.
Satisfaction and concordance with interventions is a
key area for research, as patients are unlikely to continue
to wear socks they are unhappy with or find uncom-
fortable. Only one study [38] addressed this important
aspect of practice, but the instrument used to determine
satisfaction was not provided, making an adequate
assessment of its appropriateness, responsiveness and
reliability difficult. Any changes in clinical outcomes
(e.g. a reduction in plantar pressure) that may have
occurred during the study period was not reported.
From the narrative analysis of articles and website
data, all socks reviewed were knitted using a weft knit
method with a variety of yarns (Additional file 1). We
noted sophisticated sock designs that included the use of
pile fabric knit structures over areas requiring extra
padding to reduce pressure, rib knit structures used to
provide compression and support structure over the
ankle and mesh or tuck knit structures allowing for free
ventilation where less protection and greater flexibility is
needed. Bertaux et al. [58] reported significant correla-
tions between physiological and sensory parameters as
well as between fabric friction and perceived comfort in
eleven subjects wearing sports socks. This highlights
that ‘comfortable’ socks provide lower friction coeffi-
cients and hence reduce the potential for skin damage.
Maximising protection and reducing friction at the
foot/sock interface is thought to be key for preventing
lesions in the at-risk diabetic foot [59]. However, param-
eters such as shear and temperature were typically not
comprehensively studied in the articles we reviewed.
Otter et al. Journal of Foot and Ankle Research  (2015) 8:9 Page 9 of 10While not a padded sock per se, the Difoprev system
reported by Banchelline et al. [39] provided a significant
increase in skin hydration. A decrease in moisture loss,
water loss and hardness is of value to people with in-
sensate feet, where autonomic neuropathy in particular
is known to cause excessive dryness and is a risk factor
for foot ulceration [13,60].
This paper represents the first review to combine a
systematic review on a topic that has not been previ-
ously addressed, together with a narrative analysis of the
key intervention. There are some limitations to consider.
Ideally a meta-analysis would be conducted in conjunc-
tion with this systematic review. However, this was not
possible as the studies using plantar pressure analysis
(the primary outcome in the majority of studies) were
conducted with various systems to measure foot pres-
sure. This results in different spatial and temporal reso-
lutions, data extraction and management approaches.
Additionally, the main plantar pressure variable was
reported differently throughout. These factors make
comparisons between trials difficult and not conducive
to further statistical analysis.
Conclusion
Altering the socks people with diabetes wear could pro-
vide a simple, cosmetically acceptable, and potentially
cost-effective method of protecting the at-risk foot in
diabetes. However, the previous studies of protective
socks were often poorly controlled, underpowered and
did not justify the primary outcomes reported. Conse-
quently, there are opportunities for further research,
including qualitative components of sock wear and sock
design, together with randomized controlled trials and
analysis of cost-effectiveness.
Additional file
Additional file 1: An overview of commercially available protective
socks, their properties, manufacturer’s claims and supporting evidence.
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